SpyGlass DS系统联合内镜逆行胰胆管造影术对胆总管结石患者的治疗作用

doi:10.6040/j.issn.1671-7554.0.2023.0351

摘要/Abstract

摘要： 目的探究SpyGlass DS系统联合内镜逆行胰胆管造影术(ERCP)对胆总管结石患者治疗的影响。方法收集接受SpyGlass DS系统联合ERCP手术患者(n=23,试验组)和单纯接受ERCP手术患者(n=51,对照组),分析手术前后两组患者手术指标和结局、Oddi括约肌基础压、收缩压高峰值和收缩频率,以及血清丙氨酸氨基转移酶(ALT)、门冬氨酸氨基转移酶(AST)和总胆红素(TBil)表达水平差异。结果与对照组相比,试验组手术时间更长,住院费用更高,住院时间更短(P<0.05),试验组一次结石清除率高于对照组(95.65% vs 72.55%,P<0.05),术后胰腺炎发生率低于对照组(8.70% vs 21.57%,P>0.05),术后试验组和对照组括约肌和肝胆功能表达水平均降低,试验组括约肌的基础压、收缩压高峰值、收缩频率高于对照组(P<0.05),ALT、AST和TBil表达水平与对照组差异无统计学意义(P>0.05)。结论 SpyGlass DS系统在ERCP取石手术中适用效果更好,可能作为一种有效的胆总管结石治疗手术方式应用于临床实践。

关键词: SpyGlass DS系统, 内镜逆行胰胆管造影术, 胆总管结石, Oddi括约肌功能

Abstract: Objective To investigate the effects of SpyGlass DS system combined with endoscopic retrograde cholangiopancreatography(ERCP)on patients with choledocholithiasis. Methods Clinical data of patients who received SpyGlass DS combined with ERCP(n=23, experimental group)and patients who received ERCP only(n=51, control group)were collected. The operation indicators and outcomes, Oddi sphincter base pressure, peak systolic blood pressure and systolic frequency, as well as differences in the expression levels of serum alanine aminotransferase(ALT), aspartate aminotransferase(AST)and total bilirubin(TBil)were analyzed. Results Compared with the control group, the experimental group had longer operation time, higher hospitalization expenses, shorter hospital stay(P<0.05), higher stone clearance rate(95.65% vs 72.55%, P<0.05), and lower incidence of postoperative pancreatitis(8.70% vs 21.57%, P>0.05). The indicators of sphincter and hepatobiliary function in experimental group and control group were decreased after surgery, and the sphincter base pressure, peak systolic blood pressure and systolic frequency of experimental group were higher than those of control group(P<0.05). There were no significant differences in the expression levels of ALT, AST and TBil between the two groups(P>0.05). Conclusion SpyGlass DS system has a good application effect in ERCP lithotomy. It may be used in clinical practice as an effective surgical method for the treatment of choledocholithiasis.

Key words: SpyGlass DS system, Endoscopic retrograde cholangiopancreatography, Choledocholithiasis, Oddi sphincter function

中图分类号:

R576

韩卓兴,林晖,段世刚,叶志荣,陈炫廷,林康强. SpyGlass DS系统联合内镜逆行胰胆管造影术对胆总管结石患者的治疗作用[J]. 山东大学学报 (医学版), 2023, 61(9): 94-100.

HAN Zhuoxing, LIN Hui, DUAN Shigang, YE Zhirong, CHEN Xuanting, LIN Kangqiang. Therapeutic effects of SpyGlass DS system combined with endoscopic retrograde cholangiopancreatography(ERCP)on patients with choledocholithiasis[J]. Journal of Shandong University (Health Sciences), 2023, 61(9): 94-100.

参考文献

[1] Cianci P, Restini E. Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches [J]. World J Gastroenterol, 2021, 27(28): 4536-4554.
[2] Pogorelic Z, Lovric M, Jukic M, et al. The laparoscopic cholecystectomy and common bile duct exploration: a single-step treatment of pediatric cholelithiasis and choledocholithiasis [J]. Children(Basel), 2022, 9(10): 1583.
[3] 中国研究型医院学会肝胆胰外科专业委员会. 肝胆管结石病经皮经肝取石手术应用指南(2021版)[J]. 中华肝胆外科杂志, 2022, 28(1): 7-14. Professional Committee of Hepatobiliary Pancreatic Surgery, Chinese Research Hospital Association. Guidelines for the application of percutaneous transhepatic lithotomy in patients with hepatolithiasis(2021 edition)[J] Chinese Journal of Hepatobiliary Surgery, 2022, 28(1): 7-14.
[4] Wee D, Izard S, Grimaldi G, et al. EUS assessment for intermediate risk of choledocholithiasis after a negative magnetic resonance cholangiopancreatography [J]. Endosc Ultrasound, 2020, 9(5): 337-344.
[5] 黄瑶,易剑锋, 周文策. 胆总管结石治疗后复发因素的研究进展[J]. 中国普通外科杂志, 2021, 30(8): 964-970. HUANG Yao, YI Jianfeng, ZHOU Wence. Research progress on recurrence factors after treatment of common bile duct stones [J] Chinese Journal of General Surgery, 2021, 30(8): 964-970.
[6] 国海超, 党彤. 胆总管结石成因的研究进展[J]. 中国继续医学教育, 2016, 8(24): 81-82. GUO haichao, DANG tong. Research progress on the causes of common bile duct stones [J] China Continuing Medical Education, 2016, 8(24): 81-82.
[7] 黄泽坚, 吴祥, 陈亚进. SpyGlass DS胆道镜系统在肝外胆管恶性肿瘤术前评估中的作用[J]. 腹部外科, 2022, 35(4): 258-260, 273. HUANG Zejian, WU Xiang, CHEN Yajin. The role of SpyGlass DS cholangioscopy system in preoperative evaluation of malignant extrahepatic bile duct tumors [J] Abdominal Surgery, 2022, 35(4): 258-260, 273.
[8] 徐雯, 苗龙, 王正峰, 等. SpyGlass TM DS直视化系统在胆道疾病诊疗中的应用[J]. 临床肝胆病杂志, 2020, 36(11): 2626-2629. XU Wen, MIAO Long, WANG Zhengfeng, et al. The application of SpyGlass TM DS direct vision system in the diagnosis and treatment of biliary tract diseases [J] Journal of Clinical Hepatobiliary Disease, 2020, 36(11): 2626-2629.
[9] 李鹏, 王拥军, 王文海. ERCP诊治指南(2018版)[J].中国实用内科杂志, 2018, 38(11): 1041-1072. LI Peng, WANG Yongjun, WANG Wenhai. ERCP Diagnosis and Treatment Guidelines(2018 Edition)[J]. Chinese Journal of Practical Internal Medicine, 2018, 38(11): 1041-1072.
[10] 张航, 刘丹青, 肖乐, 等. ERCP联合SpyGlass系统治疗高危胆囊结石合并继发胆总管结石可行性研究[J]. 中国实用外科杂志, 2018, 38(11): 1310-1313. ZHANG Hang, LIU Danqing, XIAO Le, et al. Feasibility study on the combination of ERCP and SpyGlass system for the treatment of high-risk gallbladder stones with secondary common bile duct stones [J] Chinese Journal of Practical Surgery, 2018, 38(11): 1310-1313.
[11] 孙敏, 陈光彬, 胡郁之, 等. EPLBD联合SEST治疗胆总管结石的疗效及对胆道括约肌功能的影响[J]. 中南医学科学杂志, 2021, 49(4): 443-446. SUN Min, CHEN Guangbin, HU Yuzhi, et al. The efficacy of EPLBD combined with SEST in the treatment of choledocholithiasis and its effect on the function of biliary Sphincter [J] Zhongnan Journal of Medical Sciences, 2021, 49(4): 443-446.
[12] Shabanzadeh DM. Incidence of gallstone disease and complications [J]. Curr Opin Gastroenterol, 2018, 34(2): 81-89.
[13] Akay T, Sari E. Identification of risk factors involved in recurrence after common bile duct stone removal with ERCP: A retrospective observational study [J]. Medicine(Baltimore), 2022, 101(9): e29037. doi: 10.1097/MD.0000000000029037.
[14] Azab M, Bharadwaj S, Jayaraj M, et al. Safety of endoscopic retrograde cholangiopancreatography(ERCP)in pregnancy: a systematic review and meta-analysis [J]. Saudi J Gastroenterol, 2019, 25(6): 341-354.
[15] 焦黎, 王军民. 不同术式内镜逆行胰胆管造影术对Oddi括约肌功能的影响研究进展[J]. 解放军医学杂志, 2022, 47(6): 607-613. JIAO Li, WANG Junmin. Research progress on the effect of different endoscopic retrograde cholangiopancreatography on Oddi Sphincter function [J] PLA Medical Journal, 2022, 47(6): 607-613.
[16] 李思萱. 胆总管结石内镜治疗的远期并发症与Oddi括约肌功能保护的研究进展[J]. 中国微创外科杂志, 2022, 28(7): 575-579. LI Sixuan. Research progress on long-term complications of endoscopic treatment of choledocholithiasis and functional protection of Oddi Sphincter [J] Chinese Journal of Minimally Invasive Surgery, 2022, 28(7): 575-579.
[17] 程海超, 贾聿明, 李胜超, 等. 胆囊切除术对Oddi括约肌功能临床影响的研究进展[J]. 肝胆胰外科杂志, 2021, 33(3): 189-192, 封3. CHENG Haichao, JIA Yuming, LI Shengchao, et al. Research progress on clinical effect of cholecystectomy on Oddi Sphincter function [J] Journal of Hepatobiliary and Pancreatic Surgery, 2021, 33(3): 189-192, Cover 3.
[18] Villavicencio Kim J, Wu GY. Update on sphincter of oddi dysfunction: a review [J]. J Clin Transl Hepatol, 2022, 10(3): 515-521.
[19] Berger Z, S AMM. Paradoxical stimulatory response of remanent sphincter of oddi to buscapina after endoscopic sphincterotomy [J]. J Neurogastroenterol Motil, 2021, 27(4): 632-638.
[20] 孙强强, 刘建中. LC+LCBDE与ERCP/EST+LC治疗胆囊结石合并胆总管结石的疗效分析[J]. 世界最新医学信息文摘, 2019(50): 47-49. SUN Qiangqiang, LIU Jianzhong. Analysis of the efficacy of LC+LCBDE and ERCP/EST+LC in the treatment of gallbladder stones combined with common bile duct stones [J]. World's Latest Medical Information Digest, 2019(50): 47-49.
[21] 王闯, 周晓华, 谭硕果, 等. EST和EPBD治疗肝外胆管结石的疗效比较[J]. 中华肝脏外科手术学电子杂志, 2021, 10(4): 390-393. WANG Chuang, ZHOU Xiaohua, TAN Shuoguo, et al. Comparison of the therapeutic effects of EST and EPBD in the treatment of extrahepatic bile duct stones [J] Chinese Online magazine of Liver Surgery, 2021, 10(4): 390-393.
[22] Tsai TJ, Lin CK, Lai KH, et al. Does preserved sphincter of Oddi function prevent common bile duct stones recurrence in patients after endoscopic papillary balloon dilation? [J]. J Chin Med Assoc, 2018, 81(4): 311-315.
[23] 张虹雨,聂静,冯燕,等. EST与EST小切口联合EPBD治疗胆总管结石的前瞻性随机对照临床研究[J]. 医学食疗与健康, 2022, 20(21): 8-11.
[24] 孙明, 王宏光, 王曼彤, 等. SpyGlass DS胆道镜在肝内胆管结石中的应用分析[J]. 中国内镜杂志, 2021, 27(5): 78-83. SUN Ming, WANG Hongguang, WANG Mantong, et al. Application analysis of SpyGlass DS cholangioscopy in intrahepatic bile duct stones [J] Chinese Journal of Endoscopy, 2021, 27(5): 78-83.
[25] 李汛, 朱晓亮, 张正聪. ERCP为主导的多镜联合手术在胆胰疾病诊疗中的应用[J]. 西部医学, 2020, 32(7): 941-945. LI Xun, ZHU Xiaoliang, ZHANG Zhengcong. The application of ERCP led multi mirror combined surgery in the diagnosis and treatment of biliary and pancreatic diseases [J] Western Medicine, 2020, 32(7): 941-945.
[26] 陈石, 吴帆. SpyGlass DS系统在临床诊疗中的应用研究进展[J]. 临床医学工程, 2019, 26(12): 1751-1752. CHEN Shi, WU Fan. Research progress on the application of SpyGlass DS system in clinical diagnosis and treatment [J] Clinical Medical Engineering, 2019, 26(12): 1751-1752.
[27] 欧小红, 陈永忠, 仝亚林. SpyGlass DS直视胆道镜系统在胆胰疾病中的诊疗价值[J]. 实用医学杂志, 2021, 37(23): 3090-3093. OU Xiaohong, CHEN Yongzhong, TONG Yalin. The diagnostic and therapeutic value of SpyGlass DS direct vision cholangioscopy system in biliary and pancreatic diseases [J] Journal of Practical Medicine, 2021, 37(23): 3090-3093.
[28] Dalal A, Patil G, Kamat N, et al. Utility of the novel spyGlass(TM)DS II system and laser lithotripsy for choledocholithiasis in pregnancy [J]. GE Port J Gastroenterol, 2022, 29(3): 172-177.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed